CASSANDRE OSCAR: Open Payments
NPI 1366794877 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,779 in 76 payments from 10 companies in 2025. Trend: 2023 $2,159 · 2024 $1,206 · 2025 $11,779
Speaker / faculty: $5,535Food & beverage: $4,253Consulting: $1,225Travel & lodging: $766
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 19 | $7,719 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $1,618 |
| ABBVIE INC. | 7 | $924 |
| Gilead Sciences, Inc. | 14 | $646 |
| Ipsen Biopharmaceuticals, Inc | 7 | $411 |
| Mirum Pharmaceuticals, Inc. | 4 | $170 |
| Boston Scientific Corporation | 1 | $170 |
| ORPHALAN INC | 3 | $76 |
| Intra-Sana Laboratories | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
Products named: REZDIFFRA, TRULANCE, XIFAXAN, IQIRVO, SKYRIZI, RINVOQ, Livdelzi, Livmarli.
Industry payments across NV — which companies pay providers there.
